Sangamo Therapeutics

Sangamo Therapeutics
https://www.sangamo.com/

Field:
Genetic Engineering

Focus:
Body

Type: Public Corporation
Founded: 1995
HQ: United States

Sangamo researches, develops and commercializes engineered DNA-binding proteins for the development of novel therapeutic strategies.
[Learn +]
Leadership
Jeffrey Marrazzo
Founder
[LinkedIn]
[Twitter]

Financial Performance


Funding


Raised Capital
Year
Type
Offered / Sold Amount
Filings
Reported by Press*
Round
2018
8M USD
Grant
2018
11M USD
Grant
Known Investors
Name
Type
HQ
Other Relevant Investments
*More data available at: [CB Insights] [CrunchBase] [PitchBook]
Related
News
CRISPR used for the first time inside the body (to restore vision)
Sangamo Therapeutics attempts to edit a gene inside the body for the first time